PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $560,000 | -14.4% | 9,235 | -1.0% | 0.03% | -22.9% |
| Q1 2021 | $654,000 | +17.2% | 9,324 | 0.0% | 0.04% | +9.4% |
| Q4 2020 | $558,000 | -24.9% | 9,324 | -24.6% | 0.03% | -17.9% |
| Q3 2020 | $743,000 | -1.1% | 12,364 | -13.7% | 0.04% | -4.9% |
| Q2 2020 | $751,000 | +55.8% | 14,322 | -0.3% | 0.04% | +57.7% |
| Q1 2020 | $482,000 | -26.0% | 14,371 | 0.0% | 0.03% | -3.7% |
| Q4 2019 | $651,000 | -25.5% | 14,371 | -37.4% | 0.03% | -12.9% |
| Q3 2019 | $874,000 | -25.9% | 22,951 | -15.4% | 0.03% | -22.5% |
| Q2 2019 | $1,180,000 | +221.5% | 27,131 | +181.2% | 0.04% | +233.3% |
| Q1 2019 | $367,000 | -79.1% | 9,650 | -76.4% | 0.01% | -80.6% |
| Q4 2018 | $1,759,000 | – | 40,890 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |